FOXM1 and hepatocellular carcinoma: To confirm the ChIP results, we constructed a set of luciferase reporter vectors driven by either the Gli2-binding site-containing FoxM1 promoter or the FoxM1-binding site-containing KIF20A promoter (Figure 2D) and performed luciferase reporter assays using HCC cells.